ArticleCancer discovery2022

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

Ashish Noronha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.